![Frédéric Duchesne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Duchesne
Directeur/Membre du Conseil chez
Cenexi SAS
Profil
Frédéric Marie Duchesne currently works at Cenexi SAS, as Director from 2021, Phinex SAS, as Director from 2021, SOPHiA GENETICS SAS, as Director, and Phixen SAS, as Director from 2021.
Mr. Duchesne also formerly worked at Pierre Fabre SA, as Chief Executive Officer-Pharmaceuticals Division from 2015 to 2019, Pierre Fabre Médicament SAS, as Chairman & CEO-Pharmaceutical Division from 2010 to 2019, Bristol-Myers Squibb SARL, as CEO-United Kingdome & Vice President-Europe, Quantum Genomics SA, as Director, Pierre Fabre Ltd., as Director, Biodexa Pharmaceuticals Plc, as Non-Executive Director from 2019 to 2020, Cegedim SA, as Director, Sanofi, as Production Manager, and Groupe GlaxoSmithKline SAS, as Vice President-Primary Care France.
Postes actifs de Frédéric Duchesne
| Sociétés | Poste | Début |
|---|---|---|
Cenexi SAS
 Cenexi SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur/Membre du Conseil | 01/01/2021 |
SOPHiA GENETICS SAS
 SOPHiA GENETICS SAS Data Processing ServicesTechnology Services Provides data processing, hosting and related activity services | Directeur/Membre du Conseil | - |
Phinex SAS
 Phinex SAS Financial ConglomeratesFinance Provides investment fund services | Directeur/Membre du Conseil | 12/03/2021 |
Phixen SAS
 Phixen SAS Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 12/03/2021 |
Anciens postes connus de Frédéric Duchesne
| Sociétés | Poste | Fin |
|---|---|---|
| QUANTUM GENOMICS | Directeur/Membre du Conseil | 23/01/2023 |
| BIODEXA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 31/03/2020 |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Corporate Officer/Principal | 30/05/2019 |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Corporate Officer/Principal | 01/01/2019 |
| SANOFI | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cegedim SA
 Cegedim SA Packaged SoftwareTechnology Services Develops practice, pharmacy and care center management software and drug database | Technology Services |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Provides pharmaceutical and health care products | Distribution Services |
Cenexi SAS
Cenexi SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Phinex SAS
Phinex SAS Financial ConglomeratesFinance Provides investment fund services | Finance |
Quantum Genomics SA
 Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases | Health Technology |
SOPHiA GENETICS SAS
SOPHiA GENETICS SAS Data Processing ServicesTechnology Services Provides data processing, hosting and related activity services | Technology Services |
Pierre Fabre Ltd.
 Pierre Fabre Ltd. Household/Personal CareConsumer Non-Durables Manufactures cosmetics, chemical and pharmaceutical products | Consumer Non-Durables |
Biodexa Pharmaceuticals Plc
 Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Groupe GlaxoSmithKline SAS
 Groupe GlaxoSmithKline SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Choisissez Zonebourse 
